Malin’s latest asset buys

Irish life sciences investment firm Malin completed its initial series of asset purchases with two more investments, yesterday, and confirmed that director and former Elan boss Kelly Martin would take over as chief executive.

Malin was set up this year by executives from former Irish drugmaker Elan and raised €330m in one of Europe’s biggest biotechnology initial public offerings (IPO) to invest in smaller, unlisted firms.

After spending the proceeds ahead of schedule, Malin said chief executive Adrian Howd, a former equity analyst with a doctorate in molecular neuroscience, would assume the new role of chief investment officer to concentrate on the clinical progression of the assets.